Cubist Systematic Strategies’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,332
Closed -$126K 3285
2025
Q1
$72.5K Sell
13,332
-125,710
-90% -$713K ﹤0.01% 2673
2024
Q4
$688K Sell
139,042
-64,847
-32% -$340K ﹤0.01% 2025
2024
Q3
$1.07M Sell
203,889
-347,455
-63% -$2M 0.01% 1795
2024
Q2
$3.78M Buy
551,344
+72,203
+15% +$661K 0.03% 945
2024
Q1
$4.93M Buy
479,141
+367,779
+330% +$2.72M 0.03% 974
2023
Q4
$923K Buy
+111,362
New +$801K 0.01% 2116

Other funds holding LFMD

Cubist Systematic Strategies's LFMD Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of LifeMD (LFMD) in Q2 2025, closing a stake of 13,332 shares — an estimated $126K sold.

Cubist Systematic Strategies first reported a position in LFMD in Q4 2023 and held it in 6 quarters. The position peaked at $4.93M in Q1 2024. 128 funds tracked by Wall St. Rank hold LFMD as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining LifeMD position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 13,332 LifeMD shares in Q2 2025, an estimated $126K.
  • Cubist Systematic Strategies first reported a position in LifeMD in Q4 2023 and held it in 6 quarters.
  • Cubist Systematic Strategies's LifeMD position peaked at $4.93M in Q1 2024.
  • 128 funds tracked by Wall St. Rank held LifeMD as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.